Corient Private Wealth’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,500
Closed -$102K 2280
2023
Q3
$102K Buy
+2,500
New +$102K ﹤0.01% 2016